Total planned funding: $1,307,792,492
Clear active filters
HTXD: Treatment: ARV Drugs
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Nigeria | $319,593,459 |
| Kenya | $169,499,012 |
| Uganda | $154,265,606 |
| Zambia | $141,430,484 |
| Mozambique | $78,413,819 |
| Tanzania | $76,148,534 |
| Ethiopia | $56,318,334 |
| South Africa | $54,810,297 |
| Côte d'Ivoire | $51,864,147 |
| Rwanda | $35,745,614 |
| Zimbabwe | $27,247,664 |
| Democratic Republic of the Congo | $25,151,182 |
| Haiti | $24,102,198 |
| Vietnam | $22,330,128 |
| Cameroon | $15,618,594 |
| Botswana | $11,526,856 |
| Caribbean Region | $9,364,409 |
| Namibia | $7,869,125 |
| West Africa Region | $6,279,450 |
| Western Hemisphere Region | $4,359,019 |
| Asia Regional Program | $3,771,910 |
| Guyana | $2,777,832 |
| Eswatini | $2,662,471 |
| enumerations.Philippines | $2,522,418 |
| Burundi | $1,695,814 |
| Ukraine | $1,000,000 |
| Malawi | $900,823 |
| South Sudan | $223,238 |
| Lesotho | $176,578 |
| China | $100,000 |
| India | $23,477 |
Organizational Types
| Private Contractor | $901,392,342 |
| NGO | $135,185,016 |
| Unknown | $116,371,061 |
| Host Country Government Agency | $49,545,264 |
| University | $48,636,367 |
| FBO | $35,522,133 |
| Implementing Agency | $11,005,000 |
| Own Agency | $8,345,412 |
| Parastatal | $1,164,000 |
| Other USG Agency | $620,897 |
| Multi-lateral Agency | $5,000 |
Program Areas
| Treatment | $1,307,792,492 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $1,307,792,492 |
Top Partner Programs
Chemonics International:
$403,034,399
View countries
Medical Access Uganda Limited:
$60,105,826
View countries